Chimerix, Inc.

CMRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue$212$324$33,824$1,979
% Growth-34.6%-99%1,609.1%
Cost of Goods Sold$0$0$447$468
Gross Profit$212$324$33,377$1,511
% Margin100%100%98.7%76.4%
R&D Expenses$74,574$68,788$71,631$73,817
G&A Expenses$22,205$24,601$22,132$18,672
SG&A Expenses$22,205$24,601$22,132$18,672
Sales & Mktg Exp.$0$0$0$0
Other Operating Expenses$0$0$0$0
Operating Expenses$96,779$93,389$93,763$92,489
Operating Income-$96,567-$93,065-$60,386-$173,400
% Margin-45,550.5%-28,723.8%-178.5%-8,762%
Other Income/Exp. Net$8,180$10,970$232,589$164
Pre-Tax Income-$88,387-$82,095$172,203-$173,236
Tax Expense$0$0$36$0
Net Income-$88,387-$82,095$172,167-$255,795
% Margin-41,692%-25,338%509%-12,925.5%
EPS-0.99-0.931.97-3.01
% Growth-6.5%-147.2%165.4%
EPS Diluted-0.99-0.931.94-3.01
Weighted Avg Shares Out89,69988,60487,55584,930
Weighted Avg Shares Out Dil89,69988,60488,77684,930
Supplemental Information
Interest Income$8,180$10,970$2,919$164
Interest Expense$0$0$0$0
Depreciation & Amortization$94$91$107$468
EBITDA-$96,473-$92,974-$60,279-$90,343
% Margin-45,506.1%-28,695.7%-178.2%-4,565.1%